Nobuhiro Yuki Selected Research

Immunoglobulin G (IgG)

12/2019	On-Membrane Dynamic Interplay between Anti-GM1 IgG Antibodies and Complement Component C1q.
1/2017	Memory B cells in Guillain-Barré syndrome.
1/2017	IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome.
11/2016	Altered gene expression of glycosyltransferases and sialyltransferases and total amount of glycosphingolipids following herpes simplex virus infection.
11/2016	Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies.
3/2016	Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.
3/2016	Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
1/2016	Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.
7/2015	Streptococcal IdeS: therapeutic potential for Guillain-Barré syndrome.
6/2015	Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuhiro Yuki Research Topics

Disease

92	Guillain-Barre Syndrome 12/2019 - 01/2002
32	Miller Fisher Syndrome (Fisher Syndrome) 01/2017 - 12/2002
22	Polyneuropathies (Polyneuropathy) 07/2017 - 01/2002
16	Infections 01/2021 - 11/2002
13	Ataxia (Dyssynergia) 04/2016 - 04/2004
11	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 03/2018 - 07/2006
10	Ophthalmoplegia (External Ophthalmoplegia) 11/2013 - 10/2002
9	Encephalitis (Encephalitis, Rasmussen) 11/2016 - 02/2004
9	Autoimmune Diseases (Autoimmune Disease) 03/2016 - 08/2004
9	Enteritis 01/2016 - 10/2002
8	Demyelinating Diseases (Demyelinating Disease) 07/2017 - 12/2007
6	Peripheral Nervous System Diseases (PNS Diseases) 03/2018 - 12/2002
6	Paralysis (Palsy) 12/2007 - 10/2002
4	Disease Progression 01/2017 - 05/2002
4	Nervous System Diseases (Neurological Disorders) 01/2015 - 03/2003
3	Gastroenteritis 01/2021 - 06/2006
3	Neuromyelitis Optica (Devic's Disease) 01/2017 - 11/2014
3	Muscle Weakness 11/2014 - 08/2004
3	Diarrhea 07/2008 - 04/2004
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2014
2	Cerebellar Ataxia (Dysmetria) 04/2016 - 03/2016
2	Multiple Sclerosis 02/2016 - 11/2014
2	Leukocytosis (Pleocytosis) 01/2016 - 03/2015
2	Cranial Nerve Diseases (Cranial Nerve Disorders) 12/2015 - 05/2006
2	Experimental Autoimmune Neuritis 12/2014 - 12/2012
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2014 - 01/2011
2	acute flaccid myelitis 05/2011 - 10/2005
1	Pain (Aches) 01/2021
1	Mydriasis 01/2018
1	Hereditary Angioedemas 01/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Nerve Degeneration 12/2016
1	Herpes Simplex 11/2016
1	Virus Diseases (Viral Diseases) 11/2016
1	Hashimoto's encephalitis 04/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2016
1	Paraneoplastic Cerebellar Degeneration 04/2016
1	Tremor (Tremors) 03/2016
1	Myasthenia Gravis 12/2015
1	Paresthesia (Dysesthesia) 12/2015
1	Lyme Disease (Disease, Lyme) 12/2015
1	Bell Palsy (Bell's Palsy) 12/2015
1	Sarcoidosis (Schaumann Disease) 12/2015

Drug/Important Bio-Agent (IBA)

75	AntibodiesIBA 12/2019 - 03/2002
58	Immunoglobulin G (IgG)IBA 12/2019 - 01/2002
50	GangliosidesIBA 01/2017 - 06/2003
29	AutoantibodiesIBA 12/2019 - 12/2005
14	Amantadine (Aman)FDA LinkGeneric 12/2015 - 03/2002
12	Immunoglobulin M (IgM)IBA 01/2017 - 03/2002
12	Intravenous Immunoglobulins (IVIG)FDA Link 11/2016 - 10/2002
12	OligosaccharidesIBA 01/2016 - 12/2004
11	AntigensIBA 12/2019 - 08/2004
10	Complement System Proteins (Complement)IBA 12/2019 - 01/2007
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2006
7	Biomarkers (Surrogate Marker)IBA 07/2017 - 08/2013
7	ganglioside M1b (GM1b)IBA 01/2015 - 02/2004
6	CarbohydratesIBA 01/2012 - 08/2004
5	EnzymesIBA 01/2017 - 05/2011
5	SialyltransferasesIBA 11/2016 - 10/2006
5	IV(4)-galactosyl-N-acetylganglioside GD1aIBA 08/2014 - 02/2004
4	Immunoglobulins (Immunoglobulin)IBA 12/2019 - 12/2005
4	EpitopesIBA 01/2017 - 01/2008
4	G(M1) GangliosideIBA 01/2012 - 08/2004
3	Sodium Channels (Sodium Channel)IBA 12/2013 - 12/2007
3	Polysaccharides (Glycans)IBA 04/2011 - 07/2007
2	Protein Isoforms (Isoforms)IBA 07/2017 - 12/2012
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2017 - 12/2016
2	Complement Inactivating AgentsIBA 01/2017 - 12/2008
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 05/2006
2	LectinsIBA 03/2016 - 01/2015
2	SugarsIBA 01/2015 - 01/2008
2	moesinIBA 12/2014 - 11/2014
2	GlycolipidsIBA 07/2014 - 12/2002
2	ImmunosorbentsIBA 01/2014 - 05/2011
2	sulfate-3-glucuronyl paraglobosideIBA 07/2006 - 05/2006
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	trisialoganglioside GT1IBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 12/2016
1	NeurotoxinsIBA 12/2016
1	GlycosphingolipidsIBA 11/2016
1	GlycosyltransferasesIBA 11/2016
1	Glutens (Glutelin)IBA 04/2016
1	TetraspaninsIBA 02/2016
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2016
1	1,3-dipropyl-8-phenylxanthineIBA 01/2016
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016
1	Glycine Receptors (Glycine Receptor)IBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	2-benzyl-3-formylpropanoic acid (BFP)IBA 12/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015
1	Contactin 1IBA 06/2015
1	radixinIBA 11/2014
1	ezrinIBA 11/2014

Therapy/Procedure

5	Therapeutics 01/2016 - 09/2004
4	Plasma Exchange 07/2015 - 09/2004
3	Immunotherapy 06/2015 - 07/2011
1	Artificial Respiration (Mechanical Ventilation) 01/2021